NCT04091295 2026-03-04
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
Available
Clinical Trials
28 trialsNCT06836648 2026-02-25
Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Available
NCT03756311 2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT03523338 2025-12-10
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
No longer available
NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
NCT05650476 2025-06-12
Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
Pfizer
Available
NCT04100694 2025-05-20
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
Merus B.V.
Approved for marketing
NCT06751524 2024-12-30
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus Inc.
Available
NCT04809584 2024-12-19
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
Stanford University
Approved for marketing
NCT05002465 2023-09-11
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
No longer available
NCT05415228 2023-05-18
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
No longer available
NCT04854369 2023-04-11
Firefly
Tulane University
No longer available
NCT04452136 2022-03-14
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer
OHSU Knight Cancer Institute
Approved for marketing
NCT03501940 2022-01-21
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
No longer available
NCT04800068 2022-01-21
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
No longer available
NCT04348682 2021-06-24
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
Jonsson Comprehensive Cancer Center
Approved for marketing
NCT04337099 2021-05-05
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Matrix Biomed, Inc.
Available
NCT04377152 2021-03-01
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer
University of California, San Francisco
Approved for marketing
NCT02826395 2020-07-24
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
No longer available
NCT02531672 2020-06-05
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Memorial Sloan Kettering Cancer Center
No longer available
NCT03554434 2020-03-02
An Expanded Access Program for AM0010 (Pegilodecakin)
Eli Lilly and Company
No longer available
NCT01834209 2018-11-07
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
No longer available
NCT01777061 2018-05-16
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
No longer available
NCT03005262 2018-04-04
MLN8237 for a Subject With Adenocarcinoma of the Prostate
The University of Texas Health Science Center at San Antonio
No longer available
NCT01217697 2017-03-24
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Approved for marketing
NCT02355054 2017-01-20
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study
Washington University School of Medicine
Approved for marketing
NCT01516762 2014-07-14
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Bayer
No longer available
NCT00636259 2008-06-11
Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
AstraZeneca
No longer available